✦ LIBER ✦

Structure of the n-butyl acetate solvate of 11β-[4-(dimethylamino)phenyl]-17β-hydroxy-17α-(1-propynyl)estra-4,9-dien-3-one

✍ Scribed by van Geerestein, V. J. ;Kanters, J. A. ;van der Sluis, P. ;Kroon, J.

Book ID: 114503446
Publisher: International Union of Crystallography
Year: 1986
Tongue: English
Weight: 369 KB
Volume: 42
Category: Article
ISSN: 0108-2701
DOI: 10.1107/s010827018609162x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure of 11β-[4-(dimethylamino)pheny

Structure of 11β-[4-(dimethylamino)phenyl]-17β-hydroxy-17α-(2-propenyl)-estra-4,9-dien-3-one

✍ van Geerestein, V. J. ;Kanters, J. A. ;Kroon, J. 📂 Article 📅 1987 🏛 International Union of Crystallography 🌐 English ⚖ 455 KB

Biotransformation of 17β-hydroxy-11β-(4-

Biotransformation of 17β-hydroxy-11β-(4-dimethylaminophenyl)17α-1-propynyl-estra-4,9-dien-3-one (RU486) in rat hepatoma variants

✍ S. Chasserot-Golaz; G. Beck; A. Venetianer 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 362 KB

An approach to the mechanism of the pote

An approach to the mechanism of the potent antiglucocorticoid: 17β-hydroxy- 11β -4-dimethylaminophenyl-17α- propynyl-estra-4,9-dien-3-one

✍ S. Chasserot-Golaz; G. Beck 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 912 KB

The photodimerization of 17β-hydroxy-est

The photodimerization of 17β-hydroxy-estra-4,9(10)-dien-3-one

✍ Manuel Debono 📂 Article 📅 1968 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Synthesis of ENT-17-(prop-1-ynyl-17β-hyd

Synthesis of ENT-17-(prop-1-ynyl-17β-hydroxy-11β-(4-(N,N-dimethylamino) -phenyl)-4,9-estradien-3-one, the antipode of RU — 38 486

✍ Eckhard Ottow; Sybille Beier; Walter Elger; David A. Henderson; Günter Neef; Rud 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 371 KB

Synthesis of high specific activity 17α-

Synthesis of high specific activity 17α-cyanomethyl-17β-hydroxy-[14α,15α-3H]estra-4,9-dien-3-one

✍ P. Droescher; J. Röomer 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 377 KB

## Abstract An improved synthesis of the tritium labelled form of the new pharmacon DIENOGEST is described. The [^14^α,15α‐^3^‐H]DIENOGEST was obtained with a specific activity of 51 Ci/mmol and a radiochemical purity > 98%.